analyst
AB
NASDAQ · ABSI
Absci Corporation
Healthcare · Biotechnology
$9.04
Up+$0.33 (+3.79%)
Updated Sep 1, 2026, 10:37 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 412.02M
- P/E ratio
- -3.44
- Dividend yield
- 0.00%
- 52-week range
- $2.24 – $12.06
- Volume
- 5.26M
- Avg. volume
- 3.49M
Price performance
ABSI price history
1M range · 21 trading sessions · Daily adjusted prices
ABSI closed at $9.04 after 21 trading sessions, up 14.00% for the selected period.
- Last close
- $9.04
- Period change
- +14.00%
- Period low
- $7.93
- Period high
- $9.99
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | $8.67 | $9.09 | $8.6198 | $9.04 | 5.26M |
| Aug 28, 2026 | $9.202 | $9.30 | $8.60 | $8.71 | 2.51M |
| Aug 27, 2026 | $9.28 | $9.6788 | $9.155 | $9.42 | 3.21M |
| Aug 26, 2026 | $9.555 | $9.65 | $8.90 | $9.22 | 2.68M |
| Aug 25, 2026 | $9.11 | $9.705 | $9.10 | $9.63 | 2.34M |
| Aug 24, 2026 | $9.33 | $9.36 | $8.75 | $8.84 | 2.2M |
| Aug 21, 2026 | $9.56 | $9.90 | $9.50 | $9.55 | 2.33M |
| Aug 20, 2026 | $9.74 | $10.03 | $9.24 | $9.28 | 2.91M |
| Aug 19, 2026 | $9.42 | $10.015 | $9.35 | $9.99 | 4.53M |
| Aug 18, 2026 | $8.87 | $9.14 | $8.55 | $8.85 | 2.48M |
| Aug 17, 2026 | $9.19 | $9.335 | $8.84 | $9.24 | 2.15M |
| Aug 14, 2026 | $9.43 | $9.435 | $8.83 | $9.18 | 2.23M |
| Aug 13, 2026 | $9.58 | $9.66 | $9.195 | $9.46 | 2.55M |
| Aug 12, 2026 | $9.02 | $9.67 | $8.64 | $9.50 | 4.04M |
| Aug 11, 2026 | $9.03 | $9.42 | $8.89 | $9.41 | 2.88M |
| Aug 10, 2026 | $9.00 | $9.47 | $8.90 | $9.01 | 2.97M |
| Aug 7, 2026 | $8.55 | $8.97 | $8.47 | $8.93 | 2.19M |
| Aug 6, 2026 | $8.22 | $8.55 | $8.13 | $8.30 | 1.77M |
| Aug 5, 2026 | $8.585 | $8.77 | $8.34 | $8.40 | 2.1M |
| Aug 4, 2026 | $8.20 | $8.585 | $8.198 | $8.48 | 1.98M |
| Aug 3, 2026 | $7.70 | $8.065 | $7.43 | $7.93 | 2.22M |
Latest ABSI news
The latest Smart Investors Daily articles mentioning ABSI.
Stock researchCompany · Earnings
Loading stock research…